Concepedia

Mo Dimbil

MD

Statistics

Publications

5

Citations

463

H-Index

5

Active since

2012

Affiliations

Columbia University(Current)

BioVentures (United States)

Mo Dimbil is an author at Columbia University specializing in adverse drug event reporting, pharmacovigilance, and pharmacology.

Publications per year

2012–2019

5

Publications

5

The Weber Effect and the United States Food and Drug Administration’s Adverse Event Reporting System (FAERS): Analysis of Sixty-Two Drugs Approved from 2006 to 2010

Keith B. Hoffman, Mo Dimbil, Colin B. Erdman et al. · Drug Safety · 2014 · 180 citations · Full text

, , +16

A Survey of the FDA's AERS Database Regarding Muscle and Tendon Adverse Events Linked to the Statin Drug Class

Keith B. Hoffman, Christina N. Kraus, Mo Dimbil et al. · PLoS ONE · 2012 · 124 citations · Full text

, , +14

Stimulated Reporting: The Impact of US Food and Drug Administration-Issued Alerts on the Adverse Event Reporting System (FAERS)

Keith B. Hoffman, A. Demakas, Mo Dimbil et al. · Drug Safety · 2014 · 110 citations · Full text

, , +16

A Pharmacovigilance Signaling System Based on FDA Regulatory Action and Post-Marketing Adverse Event Reports

Keith B. Hoffman, Mo Dimbil, Nicholas P. Tatonetti et al. · Drug Safety · 2016 · 35 citations

, , +16

Serious Cardiovascular Adverse Events Reported with Intravenous Sedatives: A Retrospective Analysis of the MedWatch Adverse Event Reporting System

Matthew S. Duprey, Nada S. Al‐Qadheeb, J. Nicholas O’Donnell et al. · Drugs - Real World Outcomes · 2019 · 14 citations · Full text

, , +16

1–5 of 5